Sio Capital Management, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 270 filers reported holding SAGE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
Sio Capital Management, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$3,025,000
-89.8%
41,900
-76.6%
0.72%
-95.7%
Q4 2017$29,516,000
+148.8%
179,200
-5.9%
16.65%
+170.4%
Q3 2017$11,862,000
+148.3%
190,400
+217.3%
6.16%
+171.0%
Q2 2017$4,778,000
-34.6%
60,000
-41.6%
2.27%
-44.4%
Q1 2017$7,306,000
+327.0%
102,800
+81.0%
4.09%
+367.6%
Q2 2016$1,711,00056,8000.87%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 181,650$15,715,0007.17%
GREAT POINT PARTNERS LLC 454,417$39,312,0006.38%
ACUTA CAPITAL PARTNERS, LLC 255,800$22,129,0006.02%
Integral Health Asset Management, LLC 195,000$16,869,0005.02%
DAFNA Capital Management LLC 181,306$15,685,0004.67%
Boxer Capital, LLC 1,094,000$94,642,0003.04%
Palo Alto Investors LP 590,200$51,058,0002.68%
Bellevue Group AG 1,567,504$135,604,0001.55%
Aristotle Atlantic Partners, LLC 160,805$13,911,0001.07%
JGP Global Gestao de Recursos Ltda. 2,618$226,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders